Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1 13Phase 1/2 9Phase 3 3Phase 2/3 3Phase NA 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Lymphoid 1Breast 1

Conditions

Stomatitis 1Pain 1Mucositis 1Burkitt Lymphoma 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20venetoclax 18Vincristine 18apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Diphenhydramine × Clear all
NCT07570173 2026-05-26

MK-1045-005

Merck Sharp & Dohme LLC

Phase 2/3 Recruiting
340 enrolled
Lymphoid

Burkitt Lymphoma

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT01837446 2013-04-23

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

Isfahan University of Medical Sciences

Phase 2/3 Completed
30 enrolled
Other

Pain, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡